InvestorsHub Logo
Followers 167
Posts 35900
Boards Moderated 4
Alias Born 10/20/2019

Re: ProfitScout post# 523

Monday, 01/24/2022 2:18:05 PM

Monday, January 24, 2022 2:18:05 PM

Post# of 633
$AVCO holding steady in this market downturn...very nice 2021 update, and 2022 guidance.

“Given our rapid progress this past year, our goal for 2022 is to focus on our core programs to drive innovation and bring about advanced technologies and new medicines to patients. Towards this end, we have decided not to move ahead with the SenlangBio acquisition. Instead, we plan to focus our resources on organic growth and strategic partnership opportunities that we believe will hold the potential to drive much greater value for our shareholders, while avoiding potentially significant dilution that would have occurred with the proposed acquisition.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALBT News